Biotechnology Ascendis Pharma A/S Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 27 August 13, 2020
Biotechnology European Medicines Agency Validates BioMarin’s Marketing Authorization Application for Vosoritide to Treat Children with Achondroplasia August 13, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reata Pharmaceuticals, Inc. – RETA August 12, 2020
Biotechnology BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 12, 2020
Biotechnology Ascendis Pharma A/S Receives Orphan Designation for TransCon(TM) CNP for the Treatment of Achondroplasia in Europe August 12, 2020
Search
Biotechnology
